TherapeuticsMD Q2 EPS $(0.24) Misses $(0.07) Estimate, Sales from Cont Ops $400.00K Miss $500.00K Estimate
Portfolio Pulse from Benzinga Newsdesk
TherapeuticsMD reported Q2 losses of $(0.24) per share, missing the analyst consensus estimate of $(0.07) by 242.86%. The company also reported quarterly sales of $400.00 thousand, missing the analyst consensus estimate of $500.00 thousand by 20.00%.
August 14, 2023 | 10:58 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
TherapeuticsMD's Q2 earnings and sales missed analyst estimates, which could negatively impact the stock in the short term.
TherapeuticsMD reported lower than expected earnings and sales for Q2. This underperformance could lead to a decrease in investor confidence and a potential drop in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100